You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 15, August 9, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (91)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Diabetes Mellitus
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Prevalence and Correlates of Elevated Serum Creatinine Levels

The Framingham Heart Study

Bruce F. Culleton, MD; Martin G. Larson, ScD; Jane C. Evans, MPH; Peter W. F. Wilson, MD; Brendan J. Barrett, MD; Patrick S. Parfrey, MD; Daniel Levy, MD

Arch Intern Med. 1999;159:1785-1790.

Background  Elevated serum creatinine (SCr) levels are a predictor of end-stage renal disease, but little is known about the prevalence of elevated SCr levels and their correlates in the community.

Methods  In this cross-sectional, community-based sample, SCr levels were measured in 6233 adults (mean age, 54 years; 54% women) who composed the "broad sample" of this investigation. A subset, consisting of 3241 individuals who were free of known renal disease, cardiovascular disease, hypertension, and diabetes, constituted the healthy reference sample. In this latter sample, sex-specific 95th percentiles for SCr levels (men, 136 µmol/L [1.5 mg/dL]; women, 120 µmol/L [1.4 mg/dL]) were labeled cutpoints. These cutpoints were applied to the broad sample in a logistic regression model to identify prevalence and correlates of elevated SCr levels.

Results  The prevalence of elevated SCr levels was 8.9% in men and 8.0% in women. Logistic regression in men identified age, treatment for hypertension (odds ratio [OR], 1.75; 95% confidence interval [CI], 1.27-2.42), and body mass index (OR, 1.08; 95% CI, 1.01-1.15) as correlates of elevated SCr levels. Additionally, men with diabetes who were receiving antihypertensive medication were more likely to have raised SCr values (OR, 2.94; 95% CI, 1.60-5.39). In women, age, use of cardiac medications (OR, 1.58; 95% CI, 1.10-2.96), and treatment for hypertension (OR, 1.42; 95% CI, 1.07-1.87) were associated with elevated SCr levels.

Conclusions  Elevated SCr levels are common in the community and are strongly associated with older age, treatment for hypertension, and diabetes. Longitudinal studies are warranted to determine the clinical outcomes of individuals with elevated levels of SCr and to examine factors related to the progression of renal disease in the community.


From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass (Drs Culleton, Larson, Wilson, and Levy and Ms Evans); the Department of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Mass (Dr Larson and Ms Evans); and the Division of Nephrology, Memorial University of Newfoundland, St John's (Drs Barrett and Parfrey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(15):1818-1819.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Race Independently Impacts Outcome of Infrapopliteal Bypass for Symptomatic Arterial Insufficiency
Rowe et al.
VASC ENDOVASCULAR SURG 2007;41:397-401.
ABSTRACT  

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial
Fox et al.
J Am Coll Cardiol 2007;49:2249-2255.
ABSTRACT | FULL TEXT  

Renal function, revascularization and risk
Hillis et al.
Eur Heart J 2007;28:782-784.
FULL TEXT  

Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers
Wannamethee et al.
Eur Heart J 2006;27:2975-2981.
ABSTRACT | FULL TEXT  

The treatment of coronary artery disease in patients with chronic kidney disease
Edwards et al.
QJM 2006;99:723-736.
ABSTRACT | FULL TEXT  

Effects of Anemia and Left Ventricular Hypertrophy on Cardiovascular Disease in Patients with Chronic Kidney Disease
Weiner et al.
J. Am. Soc. Nephrol. 2005;16:1803-1810.
ABSTRACT | FULL TEXT  

Risk Factors for Development of Decreased Kidney Function in a Southeast Asian Population: A 12-Year Cohort Study
Domrongkitchaiporn et al.
J. Am. Soc. Nephrol. 2005;16:791-799.
ABSTRACT | FULL TEXT  

Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA)
Baggio et al.
Nephrol Dial Transplant 2005;20:114-123.
ABSTRACT | FULL TEXT  

Myocardial Infarction Enhances Progressive Renal Damage in an Experimental Model for Cardio-Renal Interaction
van Dokkum et al.
J. Am. Soc. Nephrol. 2004;15:3103-3110.
ABSTRACT | FULL TEXT  

Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial
Best et al.
J Am Coll Cardiol 2004;44:1786-1791.
ABSTRACT | FULL TEXT  

Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality: A Pooled Analysis of Community-Based Studies
Weiner et al.
J. Am. Soc. Nephrol. 2004;15:1307-1315.
ABSTRACT | FULL TEXT  

Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox et al.
JAMA 2004;291:844-850.
ABSTRACT | FULL TEXT  

Pharmacokinetics of Intravenous, Single-Dose Tiotropium in Subjects with Different Degrees of Renal Impairment
Turck et al.
J Clin Pharmacol 2004;44:163-172.
ABSTRACT | FULL TEXT  

Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland
Haroun et al.
J. Am. Soc. Nephrol. 2003;14:2934-2941.
ABSTRACT | FULL TEXT  

Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE)
Santopinto et al.
Heart 2003;89:1003-1008.
ABSTRACT | FULL TEXT  

Chronic Kidney Disease, Mortality, and Treatment Strategies among Patients with Clinically Significant Coronary Artery Disease
Reddan et al.
J. Am. Soc. Nephrol. 2003;14:2373-2380.
ABSTRACT | FULL TEXT  

Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study
Chadban et al.
J. Am. Soc. Nephrol. 2003;14:S131-138.
ABSTRACT | FULL TEXT  

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
Fried et al.
J Am Coll Cardiol 2003;41:1364-1372.
ABSTRACT | FULL TEXT  

Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial
Hillege et al.
Eur Heart J 2003;24:412-420.
ABSTRACT | FULL TEXT  

Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients
Swedko et al.
Arch Intern Med 2003;163:356-360.
ABSTRACT | FULL TEXT  

Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III)
Clase et al.
J. Am. Soc. Nephrol. 2002;13:1338-1349.
ABSTRACT | FULL TEXT  

The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with chronic renal failure
Gruberg et al.
J Am Coll Cardiol 2001;38:1049-1053.
ABSTRACT | FULL TEXT  

Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease
Shlipak et al.
J Am Coll Cardiol 2001;38:705-711.
ABSTRACT | FULL TEXT  

High-Normal Serum Creatinine Concentration Is a Predictor of Cardiovascular Risk in Essential Hypertension
Schillaci et al.
Arch Intern Med 2001;161:886-891.
ABSTRACT | FULL TEXT  

Anaesthetic management of patients with diabetes mellitus
McAnulty et al.
Br J Anaesth 2000;85:80-90.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.